Archive for August 2017

Taxotere Litigation Nationwide Update

Taxotere Litigation

Taxotere litigation is now slated to move forward with several bellwether trials scheduled to begin on September 21, 2018 in federal court in the Eastern District of Louisiana. To date there are some 1,272 lawsuits that have been filed against Sanofi-Aventis that involve claims of permanent hair loss in breast cancer patients who have used…

Read More

Disclosure: Johnson and Johnson Product Liability Claims

Talcum Powder Litigation: J&J Logo

Johnson and Johnson product liability claims are described in detail in the company’s quarterly report filed with the SEC and released earlier this month. The company declines to put losses on its balance sheet “until a loss is determined to be probable and can be reasonably estimated.” According to Johnson and Johnson: The most significant…

Read More

Talcum Powder Litigation Award Set In California

talcum powder litigation update

Talcum powder litigation reached a new high point yesterday when a California jury awarded a plaintiff a $417 million award in a suit connecting talcum to ovarian cancer. The court ordered Johnson & Johnson to pay the record sum to Eva Escheverria, a 63 year old medical receptionist, who had used Johnson’s Baby Powder on…

Read More

Opioid Drug Lawsuits Continue to Target Manufacturers

Drug Lawsuits

South Carolina and the cities of Birmingham, Alabama and Cincinnati, Ohio have become the latest state and cities to file opioid drug lawsuits. The city lawsuits allege that opioid manufacturers flooded states and municipalities with suspiciously large orders of drugs like oxycodone and hydrocodone. Birmingham and Cincinnati have filed suit against McKesson Corp., Cardinal Health and AmerisourceBergen…

Read More

Talcum Powder Litigation Continues Nationwide

Talcum Powder Litigation: J&J Logo

Talcum powder litigation continues nationwide as manufacturer Johnson & Johnson vows to continue fighting each claim. The tough stance comes despite the fact that Johnson & Johnson has thus far lost in four instances of talcum powder litigation it which it is alleged that the regular use of talcum powder can lead to ovarian cancer.…

Read More

FDA Updates Warning on Intragastric Balloons After 5 Deaths

FDA Approves: New Hepatitis C Drug

The FDA last week issued an updated warning letter on intragastric balloons to alert health care providers to 5 deaths that occurred over the last year in patients treated for obesity with the liquid-filled balloon systems.  The original warning, that the FDA issued 6 months ago,  addressed two possible adverse events, over inflation with either liquid of…

Read More

Drug Recall Warnings: PharmaTech, Zydus Pharma

FDA Approves: New Hepatitis C Drug

The FDA has announced two drug recall warnings: PharmaTech, Zydus Pharma. One is a voluntary recall for Diocto Liquid and Diocto Syrup manufactured by PharmaTech of Davie, Florida. The other, also a voluntary recall, for Divalproex Sodium produced by the India based firm Zydus. The drug recall warnings of the PharmaTech products is due to a risk…

Read More

Drug Recalls on the Rise Dramatically by 444 Percent

Drug recalls rose by 444 percent

The last quarter saw more drug recalls than at any time in the past three years. The number of recalls increased by 6 percent over the prior quarter to 86, and the volume of drug units in homes and on store shelves increased by 444 percent. The source of that information is Recall Index released today…

Read More

CVS Sued over Alleged Fraudulent Drug Pricing

A California woman is suing CVS Health Corp. claiming that the nation’s largest drugstore chain is charging customers co-payments for some prescription drugs that actually exceed the cost of the drugs. According to the named plaintiff, Megan Schultz, CVS is surreptitiously charging customers who use insurance more for drugs, though their co-payments, more than the…

Read More

Doctors Want Better Info From Pharma Reps

pharma reps technology

Pharma reps are failing to keep up with the digital age, according to analysis from a leading medical research firm. A new study just released by DRG Digital’s Manhattan Research indicates that pharma reps are showing doctors news that they’ve already seen. Poll respondents say that in more than half of the time (51%) the reps are…

Read More